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1) Introduction 
Insight in symptom prevalence and symptom control in the elderly with incurable cancer is 
lacking.   
 
2) Aim 
Development and validation of an instrument to collect data on symptom prevalence and 
symptom control in the elderly with incurable cancer. 
 
3) Method 
This study consisted of two phases. In the first phase domains and items were identified based on 
an extensive literature review. The initial set of items was validated by a Delphi procedure 
including a panel of 11 experts in oncology, palliative care and/or geriatric care. Face- and 
content validity of the preliminary instrument was assessed. The experts were invited to evaluate 
all domains and items on clarity of wording and relevance. Relevance was quantified according 
to the Item Content Validity Index (I-CVI, target value > 0.8).  
 
 
4) Results 
The instrument to collect data on symptoms contained 58 items and enables to measure frequency 
and intensity of (1) physical, (2) psychological, (3) social, and (4) existential symptoms. The 
instrument to collect data on interventions consisted of 86 items and has a focus on eight 
symptoms: (1) pain, (2) nausea, (3) vomiting, (4) dyspnoea, (5) obstipation, (6) cachexia, (7) 
fatigue, and (8) depression. The I-CVI of the included items was > 0.8 and resulted in a final 
inclusion of 40 items in each instrument. To assess clarity of wording for the aimed population, 
the validated instrument on symptoms was pilot tested in a sample of ten geriatric patients.  
 
5) Conclusion 
This study resulted in two validated instruments, which will be used to assess symptom 
prevalence and symptom control in the elderly with incurable cancer. These instruments will be 
used to acquire knowledge about frequency and intensity of symptoms and interventions aimed at 
controlling these symptoms.  
 
 
